Showing results (21-30 of 100) with videos related to
Sort By:
Pageof 10
Plos One|October 26, 2022
Visualization of dental plaque with a 3D-intraoral-scanner-A tool for whole mouth planimetryKatja Jung, Katja Giese-Kraft, Melanie Fischer, et al.Pharmaceutics|April 28, 2023
Pulmonary Application of Novel Antigen-Loaded Chitosan Nano-Particles Co-Administered with the Mucosal Adjuvant C-Di-AMP Resulted in Enhanced Immune Stimulation and Dose Sparing CapacityThomas Ebensen, Andrea Arntz, Kai Schulze, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2007
A pegylated derivative of alpha-galactosylceramide exhibits improved biological propertiesThomas Ebensen, Claudia Link, Peggy Riese, et al.Human Gene Therapy|October 5, 2013
HLA-universal platelet transfusions prevent platelet refractoriness in a mouse modelChristiane Gras, Kai Schulze, Lilia Goudeva, et al.Current Topics in Microbiology and Immunology|July 3, 2016
New Horizons in the Development of Novel Needle-Free Immunization Strategies to Increase Vaccination EfficacyKai Schulze, Thomas Ebensen, Peggy Riese, et al.Nanomedicine : Nanotechnology, Biology, and Medicine|September 10, 2017
Bivalent mucosal peptide vaccines administered using the LCP carrier system stimulate protective immune responses against Streptococcus pyogenes infectionKai Schulze, Thomas Ebensen, Saranya Chandrudu, et al.Pharmaceutics|March 29, 2023
Protective Efficacy of a Mucosal Influenza Vaccine Formulation Based on the Recombinant Nucleoprotein Co-Administered with a TLR2/6 Agonist BPPcysMPEGMaria Victoria Sanchez, Thomas Ebensen, Kai Schulze, et al.Biological Trace Element Research|July 6, 2004
Effect of selenite combined with chemotherapeutic agents on the proliferation of human carcinoma cell linesClaudia P Schroeder, Eva M Goeldner, Kai Schulze-Forster, et al.Nanomedicine : Nanotechnology, Biology, and Medicine|September 10, 2014
Efficient nanoparticle-mediated needle-free transcutaneous vaccination via hair follicles requires adjuvantationAnkit Mittal, Kai Schulze, Thomas Ebensen, et al.Vaccine|July 20, 2019
The STING activator c-di-AMP exerts superior adjuvant properties than the formulation poly(I:C)/CpG after subcutaneous vaccination with soluble protein antigen or DEC-205-mediated antigen targeting to dendritic cellsJulia Volckmar, Laura Knop, Sabine Stegemann-Koniszewski, et al.Pageof 10